However, the difference in time to clinical resolution between placebo and peramivir groups did not reach statistical significance due to the limited sample size and the study was terminated ( de Jong et al., 2014 ).
← all excerpts
Peramivir: A Novel Intravenous Neuraminidase Inhibitor for Treatment of Acute Influenza Infections.
1
—
—